BioMelbourne Network CEO on MELBOURNE 4.0 Steering Committee
September 2015 The Committee for Melbourne has announced the members of the MELBOURNE 4.0 Steering Committee. The Steering Committee will drive the MELBOURNE 4.0 engagement process and ensure concrete policy initiatives are identified. Reflective of the Committee for…
MTP Connect Competitiveness Plan Consultation Lunch (September 2016)
September 2016 A new pathway for engagement with the Federal Government on issues concerning the sector is through the recently established Industry Growth Centres. Last week, BioMelbourne Network held a CEO lunch with Sue MacLeman, CEO MTPConnect as…
MyGolgi – Winners of the Innovation Showcase Scholarship
Melbourne-based health technology start-up company, MyGolgi, have won the 2016 Victorian State Government supported Innovation Showcase Scholarship. MyGolgi offer an easy-to-use wearable that provides consumers with continuous feedback for injury rehabilitation and prevention. The innovative device consists of…
Andrew Maxwell joins BioMelbourne Network Board
The BioMelbourne network is delighted to be able to announce that Andrew Maxwell is joining our Board of Directors as of this month. As the Managing Director of Chatsworth Associates, Andrew has worked with innovators, entrepreneurs and established…
Biomedical Breakthroughs takes close look at our bodies at Melbourne Museum
If you’re reading this through the misery of a mid-winter flu, at least you’re better off than the poor Bendigo boy who found himself in World War I with a bullet wound in the arm, tuberculosis in the…
Bridge to MassChallenge open for applications
Applications are now open until September 20th, for an Australia-wide startup competition targeting the highest-impact, highest-potential entrepreneurs. The competition will bring together international judges and collaborate with Australian ecosystem leaders to identify the top startups. Finalists will receive…
Melbourne based Planet innovation tops the AFR 50 Most Innovative Companies 2016 list
Every year millions of people die or become gravely ill from infectious diseases such as influenza, HIV, Chlamydia and Zika virus. Currently, 80 per cent of all tests for infectious diseases involve taking a patient sample and sending…
Accelerating Commercialisation – Entrepreneurs’ Programme August Funding Offers
The Turnbull Government today announced that twenty businesses across Australia will be offered $11.3 million in Entrepreneurs’ Programme grants to help them break into new and international markets.A 3-D printed jaw joint replacement, termite-proof building materials and a…
Gordagen Receives AUD$1.3M R&D Tax Incentive
Gordagen Pharmaceuticals, a private Australian company developing biopharmaceuticals and nutraceuticals based on the medicinal properties of tocotrienols, is pleased to announce it has received a Research and Development Tax Incentive Refund of AUD$1.3 million for the 2015/2016 financial…
Fight Club – A Personal Account of Immunotherapy Treatment in Melbourne
A personal journey illustrating the potential benefits of immunotherapy and also featuring several leading oncology practitioners based in Melbourne When Steven Jones-Evans was diagnosed with bladder cancer, the prognosis was grim. His only hope was new – and expensive…
Stopping superbugs with a protective coat – CSIRO
Around the world 700,000 people die of drug resistant infections a year, and that figure could rise to 10 million a year by 2050. The resulting financial cost is predicted to reach $100 trillion USD. It’s a global problem…
AdAlta Ltd lists on the ASX
Melbourne-based company, and BioMelbourne Network Member, AdAlta Limited has listed on the ASX. AdAlta is a drug discovery and development company focused on using its powerful technology platform to generate a promising new class of protein therapeutics, known…
